Millennium Management
CNCE

Millennium Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Millennium Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-93,200
Closed -$1.13M – 4620
2019
Q1 		$1.13M Buy
+93,200
New +$1.37M ﹤0.01% 2790

Millennium Management's CNCE Position: Q1 2023 in Review

Millennium Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 1,441,735 shares — an estimated $8.42M sold.

Millennium Management first reported a position in CNCE in Q1 2014 and held it in 35 quarters. The position peaked at $18.8M in Q4 2017. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

  • Millennium Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Millennium Management sold 1,441,735 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $8.42M.
  • Millennium Management first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 35 quarters.
  • Millennium Management's Concert Pharmaceuticals, Inc. position peaked at $18.8M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.